InterCure Ltd.
NASDAQ Global MarketTotal Valuation
InterCure Ltd. carries a market capitalization of 57.15M, placing it among publicly traded companies globally. Its enterprise value stands at 357.21M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 57.15M |
| Enterprise Value | 357.21M |
Share Statistics
InterCure Ltd. currently has 45.57M shares outstanding.
| Shares Outstanding | 45.57M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
InterCure Ltd. trades at a trailing price-to-earnings ratio of 13.31. The price-to-sales ratio is 0.67, and the price-to-book ratio stands at 0.56.
| PE Ratio | 13.31 |
| PS Ratio | 0.67 |
| PB Ratio | 0.56 |
| P/TBV Ratio | 1.14 |
| P/FCF Ratio | 53.06 |
| P/OCF Ratio | -65.14 |
Enterprise Valuation
On an enterprise value basis, InterCure Ltd. trades at an EV/EBITDA multiple of 13.24 and an EV/FCF ratio of 5.03. The EV/Sales ratio of 0.86 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 21.34 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.86 |
| EV / EBITDA | 13.24 |
| EV / EBIT | 21.34 |
| EV / FCF | 5.03 |
Financial Position
InterCure Ltd. maintains a current ratio of 1.90, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 30.86, indicating elevated leverage, while an interest coverage ratio of 1.32 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.90 |
| Quick Ratio | 1.14 |
| Debt / Equity | 30.86 |
| Debt / EBITDA | 6.03 |
| Interest Coverage | 1.32 |
Financial Efficiency
InterCure Ltd. posts a return on equity of 4.33 and a return on invested capital of 4.62.
| Return on Equity (ROE) | 4.33 |
| Return on Assets (ROA) | 2.56 |
| Return on Invested Capital (ROIC) | 4.62 |
| Return on Capital Employed (ROCE) | 2.91 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.28 |
Taxes
Over the trailing twelve months, InterCure Ltd. has paid -11.99M in income taxes, reflecting an effective tax rate of 125.27.
| Income Tax | -11.99M |
| Effective Tax Rate | 125.27 |
Stock Price Statistics
InterCure Ltd.'s stock has declined approximately -33.33333% over the past 52 weeks. The 50-day moving average sits at 0.93, while the 200-day moving average is 1.08.
| Beta (5Y) | N/A |
| 52-Week Price Change | -33.33333% |
| 50-Day Moving Average | 0.93 |
| 200-Day Moving Average | 1.08 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, InterCure Ltd. generated 414.79M in revenue and converted that into 20.90M in net income, yielding earnings per share of 0.39. EBITDA reached 26.98M, while operating income came in at 16.74M.
| Revenue | 414.79M |
| Gross Profit | 139.04M |
| Operating Income | 16.74M |
| Pretax Income | 5.40M |
| Net Income | 20.90M |
| EBITDA | 26.98M |
| EBIT | 16.74M |
| Earnings Per Share (EPS) | 0.39 |
Balance Sheet
InterCure Ltd. holds 102.85M in cash and equivalents against 162.84M in total debt, resulting in a net debt position of 38.89M. Total book value stands at 497.83M, with working capital of 186.75M providing operational flexibility.
| Cash & Cash Equivalents | 102.85M |
| Total Debt | 162.84M |
| Net Debt | 38.89M |
| Equity (Book Value) | 497.83M |
| Book Value Per Share | 11.30 |
| Working Capital | 186.75M |
Cash Flow
InterCure Ltd. produced -4.27M in operating cash flow over the past twelve months. After subtracting -9.52M in capital expenditures, free cash flow totaled -13.79M - equivalent to -0.31 per share.
| Operating Cash Flow | -4.27M |
| Capital Expenditures | -9.52M |
| Free Cash Flow | -13.79M |
| FCF Per Share | -0.31 |
Margins
InterCure Ltd. operates with a gross margin of 33.52, reflecting its pricing power and cost economics. The operating margin of 4.04 and net profit margin of 5.04 provide insight into operational efficiency.
| Gross Margin | 33.52 |
| Operating Margin | 4.04 |
| Pretax Margin | 1.30 |
| Profit Margin | 5.04 |
| EBITDA Margin | 6.51 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -1.76 |
| FCF Yield | 1.88 |
Stock Splits
InterCure Ltd.'s most recent stock split took place on April 8, 2021 with a 4:1 split ratio.
| Last Split Date | 4/8/2021 |
| Split Ratio | 4:1 |
Scores
InterCure Ltd. posts an Altman Z-Score of 1.43, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.43 |